Skip to main content
Menu

AlphaLISA SureFire Ultra Human and Mouse Total DDR2 Detection Kit, 100 Assay Points

The AlphaLISA™ SureFire® Ultra™ Human and Mouse Total DDR2 assay is a sandwich immunoassay for quantitative detection of total DDR2 in cellular lysates using Alpha Technology.

Feature Specification
Application Cell Signaling
Protocol Time 2h at RT
Sample Volume 30 µL

The AlphaLISA™ SureFire® Ultra™ Human and Mouse Total DDR2 assay is a sandwich immunoassay for quantitative detection of total DDR2 in cellular lysates using Alpha Technology.

Product variants
Unit Size: 100 assay points
Part #:
ALSU-TDDR2-A-HV
List price
USD 722.00
Your online price:
Unit Size: 500 assay points
Part #:
ALSU-TDDR2-A500
List price
USD 2,441.00
Your online price:
Unit Size: 10,000 assay points
Part #:
ALSU-TDDR2-A10K
List price
USD 14,688.00
Your online price:
Unit Size: 50,000 assay points
Part #:
ALSU-TDDR2-A50K
List price
USD 46,690.00
Your online price:
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).

Loading...

Overview

Discoidin Domain Receptor 2 (DDR2) is a receptor tyrosine kinase activated by fibrillar collagens in the extracellular matrix, particularly collagen types I, II, and III. DDR2 regulates cell adhesion, migration, proliferation, and matrix metalloproteinase (MMP) expression, playing crucial roles in tissue development, wound healing, and fibrosis. Upon collagen binding, DDR2 undergoes sustained autophosphorylation and activates downstream signaling through MAPK, PI3K/AKT, and Src pathways. Mutations and overexpression of DDR2 are implicated in various cancers, including lung squamous cell carcinoma, breast cancer, and head and neck cancers, where it promotes invasion, metastasis, and drug resistance. DDR2 is also associated with fibrotic diseases and skeletal disorders. Emerging therapeutic strategies target DDR2 to inhibit tumor progression and reduce pathological fibrosis.

The AlphaLISA SureFire Ultra Human and Mouse Total DDR2 is a sandwich immunoassay for the quantitative detection of total DDR2 in cellular lysates, using Alpha Technology.

Formats:

  • The HV (high volume) kit contains reagents to run 100 wells in 96-well format, using a 60 μL reaction volume.
  • The 500-point kit contains enough reagents to run 500 wells in 384-well format, using a 20 μL reaction volume.
  • The 10,000-point kit contains enough reagents to run 10,000 wells in 384-well format, using a 20 μL reaction volume.
  • The 50,000-point kit contains enough reagents to run 50,000 wells in 384-well format, using a 20 μL reaction volume.

AlphaLISA SureFire Ultra kits are compatible with:

  • Cell and tissue lysates
  • Antibody modulators
  • Biotherapeutic antibodies

AlphaLISA SureFire Ultra kits can be used for:

  • Cellular kinase assays
  • Receptor activation studies
  • High-throughput screening for preclinical studies

How it works

Total-AlphaLISA SureFire Ultra assay principle

The Total-AlphaLISA SureFire Ultra assay measures the expression level of a protein target in a cell lysate.

The Total-AlphaLISA SureFire Ultra assay uses two antibodies which recognize two different distal epitopes on the targeted protein. AlphaLISA assays require two bead types: Acceptor and Donor beads. Acceptor beads are coated with a proprietary CaptSure™ agent to specifically immobilize the assay specific antibody, labeled with a CaptSure tag. Donor beads are coated with streptavidin to capture one of the detection antibodies, which is biotinylated. In the presence of targeted protein, the two antibodies bring the Donor and Acceptor beads in close proximity whereby the singlet oxygen transfers energy to excite the Acceptor bead, allowing the generation of a luminescent Alpha signal. The amount of light emission is directly proportional to the quantity of protein present in the sample.

assay-principle-Total-AlphaLISA-Surefire-Ultra.jpg

 

Total-AlphaLISA SureFire Ultra two-plate assay protocol

The two-plate protocol involves culturing and treating the cells in a 96-well plate before lysis, then transferring lysates into a 384-well OptiPlate™ plate before the addition of Total-AlphaLISA SureFire Ultra detection reagents. This protocol permits the cells viability and confluence to be monitored. In addition, lysates from a single well can be used to measure multiple targets.

2 plates assay protocol AlphaLISA Surefire Ultra Total assay

Total-AlphaLISA SureFire Ultra one-plate assay protocol

Detection of Total target protein with AlphaLISA SureFire Ultra reagents can be performed in a single plate used for culturing, treatment, and lysis. No washing steps are required. This HTS designed protocol allows for miniaturization while maintaining AlphaLISA SureFire Ultra quality.

1-plate-assay-protocol-AlphaLISA-Surefire-Ultra-Total-assay

Assay validation

Collagen I induces time dependent phosphorylation of DDR2 (Tyr740)

HT-1080 cells were seeded in a 96-well plate (60,000 cells/well) in complete medium and incubated overnight at 37°C, 5% CO2. The cells were treated with 100 µg/mL of Collagen I (derived from rat tail) for indicated times.

After treatment, the cells were lysed with 50 µL of Lysis Buffer B for 10 minutes at RT with shaking (350 rpm). DDR2 Phospho (Tyr740) and Total levels were evaluated using respective AlphaLISA SureFire Ultra assays. For the detection step, 10 µL of cell lysate (approximately 12,000 cells) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at RT. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.

As expected, Collagen I triggered a time dependent increase in the levels of Phospho DDR2 (Tyr740) with no change to the Total DDR2 levels.

Collagen I induces time dependent phosphorylation of DDR2 (Tyr740)

Collagen I induces DDR2 phosphorylation in a dose dependent manner

HT-1080 cells were seeded in a 96-well plate (60,000 cells/well) in complete medium and incubated overnight at 37°C, 5% CO2. The cells were treated with increasing concentrations of Collagen I (derived from rat tail) for 4 hours.

After treatment, the cells were lysed with 50 µL of Lysis Buffer B for 10 minutes at RT with shaking (350 rpm). DDR2 Phospho (Tyr740) and Total levels were evaluated using respective AlphaLISA SureFire Ultra assays. For the detection step, 10 µL of cell lysate (approximately 12,000 cells) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at RT. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.

Collagen I treatment triggered a dose-dependent increase in the levels of Phospho DDR2 (Tyr740) with no change to the Total DDR2 levels.

Collagen I induces DDR2 phosphorylation in a dose dependent manner

Pervanadate induces Tyr740 phosphorylation in a dose dependent manner

RD and C2C12 cells were seeded in a 96-well plate (50,000 cells/well) in complete medium and incubated overnight at 37°C, 5% CO2. The cells were treated with increasing concentrations of pervanadate for 30 minutes.

After treatment, the cells were lysed with 50 µL of Lysis Buffer B for 10 minutes at RT with shaking (350 rpm). DDR2 Phospho (Tyr740) and Total levels were evaluated using respective AlphaLISA SureFire Ultra assays. For the detection step, 10 µL of cell lysate (approximately 10,000 cells) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at RT. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.

As expected, pervanadate triggered a dose-dependent increase in the levels of Phospho DDR2 (Tyr740) while total levels remained unchanged.

Pervanadate induces Tyr740 phosphorylation in a dose dependent manner
Pervanadate induces Tyr740 phosphorylation in a dose dependent manner

Inhibition of DDR2 phosphorylation in Dasatinib treated cells

HT-1080 cells were seeded in a 96-well plate (50,000 cells/well) in complete medium and incubated overnight at 37°C, 5% CO2. The cells were treated for 2 hours with increasing concentrations of Dasatinib, all media was removed and then followed by treatment with 100 µg/mL Collagen I (derived from rat tail) for 4 hours.

After treatment, the cells were lysed with 50 µL of Lysis Buffer B for 10 minutes at RT with shaking (350 rpm). DDR2 Phospho (Tyr740) and Total levels were evaluated using respective AlphaLISA SureFire Ultra assays. For the detection step, 10 µL of cell lysate (approximately 10,000 cells) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at RT. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.

As expected, Dasatinib triggered a dose-dependent decrease in the levels of Phospho DDR2 (Tyr740) while total levels remained unchanged.

Inhibition of DDR2 phosphorylation in Dasatinib treated cells

Assay specificity/selectivity

Differential expression of DDR2 Total and DDR1 Total in relevant cell lines

Expression of DDR2 and DDR1 was evaluated in various cell lines using the AlphaLISA SureFire Ultra assay kit.

For the detection step, 10 µL of lysate (approximately 50,000 cells) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at room temperature. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.

A significant difference in expression profiles was observed between DDR2 and DDR1. As expected, DDR2 was only detected in RD and SH-SY5Y cells while DDR1 expression was observed across various cell lines.

Differential expression of DDR2 Total and DDR1 Total in relevant cell lines

Specifications

Application
Cell Signaling
Automation Compatible
Yes
Brand
AlphaLISA SureFire Ultra
Detection Modality
Alpha
Product Group
Kit
Protocol Time
2h at RT
Sample Volume
30 µL
Shipping Conditions
Shipped in Blue Ice
Target
DDR2
Target Class
Phosphoproteins
Target Species
Human
Mouse
Technology
Alpha
Therapeutic Area
NASH/Fibrosis
Oncology
Unit Size
100 assay points

Resources

Are you looking for resources, click on the resource type to explore further.

1-4 of 4 Resources
Brochure Icon
Brochure
Alpha assays and reagents catalog

Alpha technolgy enables the rapid and straightforward mesaure of virtually any target. This includes enzymes, receptor-ligand...

Guide Icon
Guide
AlphaLISA SureFire Ultra: the ultimate guide for successful experiments

The definitive guide for setting up a successful AlphaLISA SureFire Ultra assay

Several biological processes are regulated by...

Brochure Icon
Brochure
Alpha SureFire Ultra no-wash immunoassay catalog

Discover Alpha SureFire® Ultra™ assays, the no-wash cellular kinase assays leveraging Revvity's exclusive bead-based technology...

Brochure Icon
Brochure
Species compatibility for HTRF, AlphaLISA SureFire Ultra and Alpha SureFire Ultra Multiplex assays

This document includes detailed tables listing HTRF™, AlphaLISA™ SureFire® Ultra™, and Alpha SureFire® Ultra™ Multiplex assays...

Scroll Icon

Revvity AI Assistant Beta